At The Retina Partners, our team of retina specialists has decades of cumulative experience providing the highest level of care for all vitreoretinal conditions and diseases. We are not jacks of all trades, but masters of one singular discipline. Nothing is more precious than your vision – trust only a team of experts to preserve it.
The doctors and staff at The Retina Partners are united in our commitment to a single principle: treating every patient as we would treat our own family member. Driven by this philosophy, we make it our top priority to provide personalized and honest care using the latest and most advanced technology in an environment of warmth, compassion, and respect. We encourage our patients to ask questions because it is the right of every patient to learn about the nature of their disease and the latest that science has to offer in understandable terms. Only in this way can the patient, the doctor, and the staff work together as a team to achieve the best results.
Diabetes Mellitus is the inability of the body to use and store sugar properly, resulting in high blood sugar levels. Over time, abnormal blood sugar levels alter the biochemistry of the blood and can cause damage to the veins, arteries and capillaries in the body.
Learn more
Macular degeneration is the most common cause of vision loss among people aged 65 years or older. It is estimated that 9-10 million Americans currently suffer from macular degeneration and that number will nearly double by the year 2050.
Learn more
The retina is a layer of nerve cells that lines the inside of the eye, like wallpaper, and enables the eye to see images. For the retina to function and remain healthy, it must stay attached to the inside of the eye because part of its blood and nutrient supply comes from the eye wall.
Learn more
The Retina Partners are committed to advancing treatment for a variety of retinal conditions. Our physicians take pride in being involved in teaching and research as it relates to the betterment of vision. As such, The Retina Partners are involved in multiple clinical trials to help with retinal conditions in the future.
